Drug delays onset of pain and quality of life deterioration for prostate cancer
Wednesday, September 25, 2013 - 13:30
in Health & Medicine
Abiraterone acetate, a recently FDA-approved drug used to treat men with metastatic castration-resistant prostate cancer, significantly delays progression of pain and quality of life deterioration when taken in conjunction with prednisone.